🧠 This Week in Neuroscience: Breakthroughs in MS, Schizophrenia, Gene Therapy & More!
In this week’s Neuroscience Updates, we spotlight the biggest headlines transforming the landscape of brain and nervous system care.
📌 What’s Inside This Week’s Update:
💊 Roche’s BTK inhibitor shows no MS progression over 96 weeks
🧬 Cartesian launches Phase 3 CAR-T trial for myasthenia gravis
🧠 XellSmart secures IND clearance for iPSC therapies in Parkinson’s, ALS & spinal cord injury
🧪 Brilaroxazine delivers sustained schizophrenia relief over 1 year
🧬 uniQure reports ninety-two percent seizure reduction with AMT-260 in epilepsy
🚀 FDA grants Fast Track to Capsida’s gene therapy for STXBP1-DEE
🧠 New 3D brain-leukemia model opens doors for CNS cancer research
🧫 Diakonos to present glioblastoma vaccine results at ASCO 2025
From first-in-class gene therapies to advanced 3D brain models, these updates are changing what’s possible in neuroscience and CNS disease treatment.
📢 Stay Ahead in Neuroscience Research!
✅ Like, share, and subscribe for weekly updates on neuroscience, neurodegeneration, and clinical trials
#Neuroscience #GeneTherapy #BrainHealth #MultipleSclerosis #Schizophrenia #Epilepsy #MyastheniaGravis #CAR_T #iPSC #CNSResearch #LucidQuest #BiotechNews #NeuroInnovation #ClinicalTrials #PharmaUpdates #Neurodegeneration